Andrew Hessel

Andrew Hessel is a micro-biologist and geneticist and entrepreneur. He founded the Pink Army Cooperative, and Humane Genomics, Inc. Between 2012-2017, he was a Distinguished Researcher at Autodesk Life Sciences. Hessel is co-chair of Bioinformatics and Biotechnology at Singularity University, and a fellow at the Institute for Science, Society, and Policy at the University of Ottawa. In 2002, he co-founded Miikana Therapeutics, a clinical-stage drug development company. The company was acquired by Entremed in 2006 for $39M in cash and milestones. He received a M.Sc. in biology from University of Calgary 1993-1995 and was Research Operations Manager at Amgen Institute 1995-2002. He has also been involved in Genome Project-Write since the start in 2016 and is currently Chairman of the Board and Co-Executive Director.